Return On Equity of Contineum Therapeutics, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Contineum Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Contineum Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -32%, a 35% increase year-over-year.
  • Contineum Therapeutics, Inc. annual Return On Equity for 2024 was -31%, a 4.7% increase from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Contineum Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -32% +18% +35% 01 Jul 2025 30 Sep 2025
Q2 2025 -30% +953% +97% 01 Apr 2025 30 Jun 2025
Q1 2025 -25% +5% +16% 01 Jan 2025 31 Mar 2025
Q4 2024 -31% +2% +4.7% 01 Oct 2024 31 Dec 2024
Q3 2024 -50% 01 Jul 2024 30 Sep 2024
Q2 2024 -983% 01 Apr 2024 30 Jun 2024
Q1 2024 -29% 01 Jan 2024 31 Mar 2024
Q4 2023 -32% 01 Oct 2023 31 Dec 2023

Contineum Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -31% +2% +4.7% 01 Jan 2024 31 Dec 2024
2023 -32% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.